Results of EGM
Faron Pharmaceuticals Ltd ("Faron" or the "Company") Results of the Extraordinary General Meeting Company Announcement, July 7, 2022 at 11:45 AM (EEST) / 9:45 AM (BST) / 04:45 AM (EDT) TURKU - FINLAND / BOSTON, MA, 7 July 2022 – Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, announces that the extraordinary general meeting (the "EGM") of the Company took place today, July 7, 2022